Video: Lynn Rees of Yourgene - my Q1 2019 nap pick

Okay he is Welsh, but there is no doubt in my mind that the new boss of Yourgene (YGEN), Lynn Rees is a class act. He recorded an interview with Proactive Investors yesterday which I viewed as very encouraging. I am expecting another very upbeat trading statement within weeks to confirm that the debt free company is now profitable and with big operational gearing and surging sales, should become very profitable really very quickly indeed. And that should driv e a material re-rate fior the shares which are now 10.75p - 11.25p, My target remains 20p and this was my Q1 nap pick and I'd expect by April the shares to be a lot closer to that target than to where they are now. Judge for yourself.

Yourgene – debt cleared this is an amazing deal: STRONG BUY (plus comment on Hardman)

Companies often describe deals as “transformational” without any real justification. Yesterday’s deal by Yourgene (YGEN) really is a game changer and is fantastic news for we loyal shareholders.

Yourgene Health (#YGEN) – agreement sees it to enter new financial year “effectively debt free”, H2 trading “anticipated to be the strongest period to date”

Video: Zak Mir interviews Adam Reynolds at the UK Investor Show City Forum

With the Sith Lord Zak Mirinterviewing him, Adam Reynolds had nothing to fear. But there were questions from the audience that were far more daunting and interesting than those posed by Britain's worst chartist.If you are, like me, a holder of Optibiotix (OPTI), Yourgene (TGEN) - my Q1 nap pick - Big Sofa (BST) - my tip of the year - or Conc epta (CPT) you will want to watch this. I have never been more bullish on the quartet. This will be our year and I know Adam feels the same. The next City forum hosted by the Sith Lord is February 25. Put the date in your diary now.

Yourgene – launch of new upgraded NIPT test: Buy

Yourgene Health (YGEN) - the company formerly known as Premaitha - has announced the launch of the Sage™ 32 plex test, a new high throughput non-invasive prenatal testing (NIPT) and analysis solution for clinical laboratories...

Yourgene Health (#YGEN) – launch of new high throughput NIPT for clinical laboratories, Sage 32 plex

Yourgene (Premaitha as was) – interims, numbers shite but still a strong buy?

There is, for we long suffering shareholders, light at the end of the tunnel though a first read of results from Yourgene (YGEN) for the six months to 30 September 2018 does not exactly bring a warm feeling. But there is a new CEO, Lyn Rees, and he seems to have a clue. Of course the Illumina patent issue was only settled during this period and that should be born in mind. To the numbers…

FinnCrap: Yourgene (Premaitha as was) shares to double

Okay FinnCrap is FinnCrap and caveat two it is house broker to Yourgene (YGEN) so take this all with a bucket load of salt. But, I agree, the shares are cheap. So here is what analyst Mark Brewer emailed out this morning after interims:

Yourgene (#YGEN) , Premaitha as was, H1 sales up 45%, steep loss but cost cutting underway, confifdent statement

Yourgene Health (#YGEN) – change of name from Premaitha Health